Prescription Drugs Market to hit US$ 2067.25 Billion by

Pune, Oct. 18, 2022 (GLOBE NEWSWIRE) — According to a new market research report titled, “Prescription Drugs Market by Product Type (Branded, Orphan, Generic, Others), Therapy (Anticoagulants, Oncology, Vaccines, Immunosuppressants, Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Global Outlook & Forecast 2022-2030″ published by Growth Plus Reports, the prescription drugs market is expected to grow at a CAGR of 8.4% from 2021 to reach US$ 2067.25 billion by 2030.

A range of immunizations and treatments are only available by prescription and are used to treat and manage specific ailments or illnesses such as cancer, heart disease, diabetes, and other rare diseases. Medications play a vital part in the treatment of numerous disorders. Drug administration is crucial for enhancing treatment results for nearly all patients suffering from serious disorders. Growing urbanization has resulted in an unhealthy diet, a rise in stress and anxiety, and sedentary lifestyles that cause low immunity, increasing the incidence of many ailments. As a result, the number of prescription medications for treating such conditions is rising.

Download PDF Brochure of Prescription Drugs Market Size – COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/prescription-drugs-market/7911

Market Drivers

The global prescription drugs market is anticipated to expand significantly throughout the forecast period. The incidence of chronic diseases such as cancer, respiratory disorders, and cardiovascular diseases is rising, which is a factor in this market expansion. In addition, the market is expanding as a result of the increased elderly population, government and private support, and the approval of more new generic drugs. Other market drivers include the development of orphan pharmaceuticals, introducing of specialty medications, and rising R&D efforts. The rapid…